Enhanced digital experience designed to improve visibility, simplify workflows and support faster de

BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative an

LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimburs

Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and

Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and

Collaboration will support leadership development, practice improvement and innovation across the na

Collaboration will support leadership development, practice improvement and innovation across the na

Shares of Labcorp Holdings Inc. (NYSE: LH - Get Free Report) hit a new 52-week high during trading o

BURLINGTON, N.C., Aug. 17, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of

The CEO liquidated 4,669 shares at a price of $320.37 per share, totaling ~$1.5 million on August 11

LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Labcorp's FDA‑approved PGDx elio® tissue complete CDx helps identify advanced melanoma patients with

LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuati

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP® (

First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with

JP Morgan analyst Lisa Gill maintains Labcorp Holdings (NYSE:LH) with a Overweight and raises the

Morgan Stanley analyst Ricky Goldwasser maintains Labcorp Holdings (NYSE:LH) with a Overweight an

Truist Securities analyst David Macdonald maintains Labcorp Holdings (NYSE:LH) with a Buy and rai

Labcorp NYSE: LH reported second-quarter 2026 revenue growth, margin expansion and higher adjusted e

Barclays analyst Jack Meehan maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises

Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript

Labcorp's Q2 earnings and revenues surpass estimates, margins expand, and its 2026 outlook is raised

The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter end

Labcorp Holdings (LH) came out with quarterly earnings of $4.99 per share, beating the Zacks Consens

Laboratory operator Labcorp raised its annual profit ​forecast and posted better-than-expected secon

Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $17.70-$18.35 to $18.10-$18.55 vs $18

Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.99 per share which beat the analyst cons

B of A Securities analyst Michael Ryskin maintains Labcorp Holdings (NYSE:LH) with a Buy and rais

Baird analyst Eric Coldwell maintains Labcorp Holdings (NYSE:LH) with a Outperform and raises the

First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated

The trial will evaluate approaches to increase germline genetic testing among at-risk family members

New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Path

MyLabcorp connects lab results, educational content and AI-enabled features in a secure, personalize

Labcorp's full test menu will be available through Epic's Aura platformIntegration builds on

Labcorp shares rise after Q1 earnings beat and higher guidance, supported by diagnostics growth and

Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $17.55-$18.25 to $17.70-$18.35 vs $17

Labcorp Holdings (NYSE:LH) raises FY2026 Adj EPS guidance from $17.55-$18.25 to $17.70-$18.35 vs $17

Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.25 per share which beat the analyst cons

KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) are the f

Developed with Amazon Web Services (AWS) and Datavant, the platform provides access to large, divers

Collaboration aims to speed the discovery, development and national availability of specialized pedi

Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Holdings (NYSE:LH) with a Outperf

 Illumina, Inc. (NASDAQ:ILMN) and Labcorp (NYSE:LH), a global leader of innovative and comprehensive

Piper Sandler analyst David Westenberg maintains Labcorp Hldgs (NYSE:LH) with a Neutral and raise

JP Morgan analyst Lisa Gill maintains Labcorp Hldgs (NYSE:LH) with a Overweight and raises the pr

Baird analyst Eric Coldwell maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the pr